Abstract
Endothelin (ET) contributes to disturbances of hepatic microcirculation after ischemia/reperfusion (I/ R) by causing vasoconstriction and enhancing leukocyte- and platelet-endothelium interactions. The aim of this study was to investigate a possible protective role of a selective endothelinA receptor antagonist (ETA-RA) in this setting. In a rat model, warm ischemia of the left lateral liver lobe was induced for 90 minutes under intraperitoneal anesthesia with xylazine and ketamine. Groups of rats consisted of shamoperated (SO, n = 14), untreated ischemia (n = 14), and treatment with BSF208075 (5 mg/kg body weight IV, n = 14). The effect of the ETA-RA on I/R was assessed by in vivo microscopy 20 to 90 minutes after reperfusion; by measurement of local tissue PO2, serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), and glutathione S-transferase α levels, and by histologic investigation. In the untreated group, sinusoidal constriction to 69.4 ± 6.7% of diameters of SO rats was observed, leading to a significant decrease in perfusion rate (74.3 ± 2.1% of SO) and liver tissue PO2 (43.5 ± 3.2% of SO) (P < 0.05). In addition, we found an increased percentage of stagnant leukocytes (142.9 ± 11.9%) and platelets (450.1 ± 62.3%) in sinusoids and in postsinusoidal venules (P < 0.05). Hepatocellular damage (ASTandALTincrease to1330 ± 157U/Land750 ± 125U/Lrespectively; previously, 27.1 ± 3.5 U/L and 28.5 ± 3.6 U/L) was detected 6 hours after reperfusion (P < 0.05). Administration of the ETA-RA before reperfusion significantly reduced I/R injury. Sinusoidal diameters were maintained (108.5 ± 6.6%), and perfusion rate (93.1 ± 1.8%) and tissue PO2 (95.3 ± 5.7%) were significantly increased (P<0.05). According to reduced leukocyte-endothelium interactions after therapy, both platelet rolling and adhesion were significantly reduced (P < 0.05). The number of stagnant platelets in sinusoids was 199.5 ± 12.3% of 50 (P < 0.05). After treatment, hepatocellular damage was decreased (AST and ALT levels after 6 hours of reperfusion: 513 ± 106 U/L and 309 ± 84 U/L, respectively; P < 0.05), and histologic changes were reduced in the long term. Our results provide evidence that the new therapeutic approach with an ETA-RA is effective in reducing hepatic I/R injury. In addition to reduced leukocyte-endothelium interactions, the number of stagnant and rolling platelets in sinusoids and venules was significantly reduced. The reduction in microcirculatory damages is responsible for better organ outcome.
Similar content being viewed by others
References
Menger MD, Vollmar B. Role of microcirculation in transplantation. Microcirculation 2000;7:291–306.
Vollmar B, Glasz J, Post S, MengerMD. Role of microcirculatory derangements in manifestation of portal triad crossclamping-induced hepatic reperfusion injury. J Surg Res 1996;60:49–54.
Flores NA, Goulielmos NV, Seghatchian MJ, et al. Myocardial ischaemia induces platelet activation with adverse electrophysiological and arrhythmogenic effects. Cardiovasc Res 1994;28:1662–1671.
Okada Y, Marchevsky AM, Zuo XJ, et al. Accumulation of platelets in rat syngeneic lung transplants: A potential factor responsible for preservation-reperfusion injury. Transplantation 1997;64:801–806.
Kuroda T, Shiohara E, Homma T, Furukawa Y, Chiba S. Effects of leukocyte and platelet depletion on ischemia-reperfusion injury to dog pancreas. Gastroenterology 1994;107:1125–1134.
Weyrich AS, Elstad MR, McEver RP, et al. Activated platelets signal chemokine synthesis by human monocytes. J Clin Invest 1996;97:1525–1534.
Deuel TF, Senior RM, Chang D, Griffin GL, Heinrikson RL, Kaiser ET. Platelet factor 4 is chemotactic for neutrophils and monocytes. Proc Natl Acad Sci U S A 1981;78:4584–4587.
Hervig T, Volundardottir T, Bakken AM, Farstad M. Thrombin-induced serotonin release as an in vitro indicator of the functional integrity of stored platelets. Clin Chem 1990;36:28–31.
Piccardoni P, Evangelista V, Piccoli A, de Gaetano G, Walz A, Cerletti C. Thrombin-activated human platelets release two NAP-2 variants that stimulate polymorphonuclear leukocytes. Thromb Haemost 1996;76:780–785.
Cywes R, Packham MA, Tietze L, et al. Role of platelets in hepatic allograft preservation injury in the rat. Hepatology 1993;18:635–647.
Cywes R, Mullen JB, Stratis MA, et al. Prediction of the outcome of transplantation in man by platelet adherence in donor liver allografts. Evidence of the importance of prepreservation injury. Transplantation 1993;56:316–323.
Khandoga A, Biberthaler P, Messmer K, et al. Platelet-endothelial cell interactions during hepatic ischemia-reperfusion in vivo: A systematic analysis. Microvasc Res 2003;65:71–77.
Noll G, Wenzel RR, Luscher TF. Endothelin and endothelin antagonists: Potential role in cardiovascular and renal disease. Mol Cell Biochem 1996;157:259–267.
Browatzki M, Schmidt J, Kubler W, Kranzhofer R. Endothelin-1 induces interleukin-6 release via activation of the transcription factor NF-kappaB in human vascular smooth muscle cells. Basic Res Cardiol 2000;95:98–105.
Eibl G, Hotz HG, Faulhaber J, Kirchengast M, Buhr HJ, Foitzik T. Effect of endothelin and endothelin receptor blockade on capillary permeability in experimental pancreatitis. Gut 2000;46:390–394.
Clozel M, Gray GA, Breu V, Loffler BM, Osterwalder R. The endothelin ETB receptor mediates both vasodilation and vasoconstriction in vivo. Biochem Biophys Res Commun 1992;186:867–873.
Housset C, Rockey DC, Bissell DM. Endothelin receptors in rat liver: Lipocytes as a contractile target for endothelin 1. Proc Natl Acad Sci U S A 1993;90:9266–9270.
Pinzani M, Milani S, De Franco R, et al. Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells. Gastroenterology 1996;110:534–548.
Massberg S, Enders G, Leiderer R, et al. Platelet-endothelial cell interactions during ischemia/reperfusion: The role of Pselectin. Blood 1998;92:507–515.
Uhlmann S, Uhlmann D, Spiegel HU. Evaluation of hepatic microcirculation by in vivo microscopy. J Invest Surg 1999;12:179–193.
Mucke I, Richter S, Menger MD, Vollmar B. Significance of hepatic arterial responsiveness for adequate tissue oxygenation upon portal vein occlusion in cirrhotic livers. Int J Colorectal Dis 2000;15:335–341.
Almond NE, Wheatley AM. Measurement of hepatic perfusion in rats by laser Doppler flowmetry. Am J Physiol 1992;262:G203-G209.
Uhlmann D, Armann B, Gaebel G, et al. Endothelin a receptor blockade reduces hepatic ischemia/reperfusion injury after warm ischemia in a pig model. Jg Astrointest Surg 2003;7:331–339.
Vollmar B, Preissler G, Menger MD. Hemorrhagic hypotension induces arteriolar vasomotion and intermittent capillary perfusion in rat pancreas. Am J Physiol 1994;267:H1936-H1940.
Jaeschke H, Farhood A. Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver. Am J Physiol 1991;260:G355-G362.
Yanagisawa M, Masaki T. Molecular biology and biochemistry of the endothelins. Trends Pharmacol Sci 1989;10:374–378.
Goto M, Takei Y, Kawano S, et al. Endothelin-1 is involved in the pathogenesis of ischemia/reperfusion liver injury by hepatic microcirculatory disturbances. Hepatology 1994;19:675–681.
Kawamura E, Yamanaka N, Okamoto E, Tomoda F, Furukawa K. Response of plasma and tissue endothelin-1 to liver ischemia and its implication in ischemia-reperfusion injury. Hepatology 1995;21:1138–1143.
Nakamura S, Nishiyama R, Serizawa A, et al. Hepatic release of endothelin-1 after warm ischemia. Reperfusion injury and its hemodynamic effect. Transplantation 1995;59:679–684.
Ota T, Hirai R, Urakami A, Soga H, Nawa S, Shimizu N. Endothelin-1 levels in portal venous blood in relation to hepatic tissue microcirculation disturbance and hepatic cell injury after ischemia/reperfusion. Surg Today 1997;27:313–320.
Battistini B, Forget MA, Laight D. Potential roles for endothelins in systemic inflammatory response syndrome with a particular relationship to cytokines. Shock 1996;5:167–183.
Ritthaler T, Gopfert T, Firth JD, Ratcliffe PJ, Kramer BK, Kurtz A. Influence of hypoxia on hepatic and renal endothelin gene expression. Pflugers Arch 1996;431:587–593.
Kawada N, Tran-Thi TA, Klein H, Decker K. The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances. Possible involvement of endothelin 1 and nitric oxide in the regulation of the sinusoidal tonus. Eur J Biochem 1993;213:815–823.
Zhang JX, Pegoli W, Jr., Clemens MG. Endothelin-1 induces direct constriction of hepatic sinusoids. Am J Physiol 1994;266:G624-G632.
Menger MD, Messmer K. [Microcirculation of skeletal muscle after ischemia and reperfusion]. Wien Med Wochenschr 1993;143:148–158.
Vollmar B, Menger MD, Glasz J, Leiderer R, Messmer K. Impact of leukocyte-endothelial cell interaction in hepatic ischemia-reperfusion injury. Am J Physiol 1994;267:G786-G793.
Vollmar B, Glasz J, Menger MD, Messmer K. Leukocytes contribute to hepatic ischemia/reperfusion injury via intercellular adhesion molecule-1-mediated venular adherence. Surgery 1995;117:195–200.
Lopez Farre A, Riesco A, Espinosa G, et al. Effect of endothelin-1 on neutrophil adhesion to endothelial cells and perfused heart. Circulation 1993;88:1166–1171.
Boros M, Massberg S, Baranyi L, Okada H, Messmer K. Endothelin 1 induces leukocyte adhesion in submucosal venules of the rat small intestine. Gastroenterology 1998; 114:103–114.
McCarron RM, Wang L, Stanimirovic DB, Spatz M. Endothelin induction of adhesion molecule expression on human brain microvascular endothelial cells. Neurosci Lett 1993; 156:31–34.
Yadav SS, Howell DN, Steeber DA, Harland RC, Tedder TF, Clavien PA. P-Selectin mediates reperfusion injury through neutrophil and platelet sequestration in the warm ischemic mouse liver. Hepatology 1999;29:1494–1502.
Vollmar B, Glasz J, Leiderer R, Post S, Menger MD. Hepatic microcirculatory perfusion failure is a determinant of liver dysfunction in warm ischemia-reperfusion. Am J Pathol 1994; 145:1421–1431.
Vollmar B, Richter S, Menger MD. Leukocyte stasis in hepatic sinusoids. Am J Physiol 1996;270:G798-G803.
Bousette N, Giaid A. Endothelin-1 in atherosclerosis and other vasculopathies. Can J Physiol Pharmacol 2003;81:578–587.
Radomski MW, Palmer RM, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987;2:1057–1058.
Goto M, Kawano S, Yoshihara H, et al. Hepatic tissue oxygenation as a predictive indicator of ischemia-reperfusion liver injury. Hepatology 1992;15:432–437.
Campbell JA, Corrigall AV, Guy A, Kirsch RE. Immunohistologic localization of alpha, mu, and pi class glutathione Stransferases in human tissues. Cancer 1991;67:1608–1613.
Redl H, Schlag G, Paul E, Davies J. Plasma glutathione Stransferase as an early marker of posttraumatic hepatic injury in non-human primates. Shock 1995;3:395–397.
Kurihara T, Akimoto M, Kurokawa K, et al. Relationship between endothelin and thromboxane A2 in rat liver microcirculation. Life Sci 1992;51:L281-L285.
Author information
Authors and Affiliations
Corresponding author
Additional information
This study was supported by a grant from the Else Kröner-Fresenius Stiftung and by a junior research fund of the Medical Faculty at the University of Leipzig.
Rights and permissions
About this article
Cite this article
Uhlmann, D., Glasser, S., Gaebel, G. et al. Improvement of postischemic hepatic microcirculation after endothelina receptor blockade—Endothelin antagonism inflfuences platelet-endothelium interactions. J Gastrointest Surg 9, 187–197 (2005). https://doi.org/10.1016/j.gassur.2004.06.006
Issue Date:
DOI: https://doi.org/10.1016/j.gassur.2004.06.006